National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1438593

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1438593
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: Headache, Malaise, Migraine, Vision blurred, Off label use, Maternal exposure during pregnancy, Product use issue, Maternal exposure during breast feeding, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PARACETAMOL
Current Illness: Breast feeding
Preexisting Conditions: Medical History/Concurrent Conditions: Pain relief; Pregnancy (Patient no longer pregnant at the time of reporting.)
Diagnostic Lab Data: Test Date: 20210602; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC 'Split Type': GBPFIZER INC2021710064

Write-up: blurred vision; feeling or being sick; Maternal exposure during breast feeding; Maternal exposure during breast feeding; Maternal exposure during breast feeding; Headache; Migraine; Maternal exposure during pregnancy; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202106141146254060-KCJ5X, Safety Report Unique Identifier: GB-MHRA-ADR 25469510. This is maternal report. A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 03Jun2021 (lot number: not known) at dose 1, single for COVID-19 immunisation. Medical history included pregnancy (patient no longer pregnant at the time of reporting), ongoing breast feeding, and pain relief. Unsure if patient has had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. Concomitant medication included paracetamol taken for pain relief from 03Jun2021. The patient experienced maternal exposure during pregnancy (on 03Jun2021), maternal exposure during breast feeding on an unspecified date; and headache and migraine on 04Jun2021. Clinical course reported: constant headache from last 10 days after getting vaccine. A severe headache that was not relieved with painkillers or was getting worse and felt worse when lie down or bend over a headache, that''s unusual and occurred with blurred vision, feeling or being sick. The medicine did not have an adverse effect on any aspect of the pregnancy. Relevant investigations or tests conducted: "NA". Patient has not tested positive for COVID-19 since having the vaccine. The patient underwent lab tests and procedures which included COVID-19 virus test: no - negative COVID-19 test on 02Jun2021. The outcome of the events headache and migraine was not recovered; and for other events was unknown. Regulatory authority assessed the events as serious: disability and medically significant. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166